BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 16105887)

  • 1. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
    Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A HLA-A2-restricted-CTL epitope variation at the N-terminal of HCV helicase and the immune response of CTLs].
    Guo HZ; Wang WL; Wang T
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):325-7. PubMed ID: 15193229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection.
    Guglietta S; Garbuglia AR; Pacciani V; Scottà C; Perrone MP; Laurenti L; Spada E; Mele A; Capobianchi MR; Taliani G; Folgori A; Vitelli A; Ruggeri L; Nicosia A; Piccolella E; Del Porto P
    Eur J Immunol; 2005 Sep; 35(9):2627-37. PubMed ID: 16114108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
    Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
    J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A complete mutational fitness map of the hepatitis C virus nonstructural 3 protease: relation to recognition by cytotoxic T lymphocytes.
    Soderholm J; Sallberg M
    J Infect Dis; 2006 Dec; 194(12):1724-8. PubMed ID: 17109345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
    Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
    J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.
    Fytili P; Dalekos GN; Schlaphoff V; Suneetha PV; Sarrazin C; Zauner W; Zachou K; Berg T; Manns MP; Klade CS; Cornberg M; Wedemeyer H
    Vaccine; 2008 Jul; 26(31):3818-26. PubMed ID: 18582999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
    Shirai M; Arichi T; Nishioka M; Nomura T; Ikeda K; Kawanishi K; Engelhard VH; Feinstone SM; Berzofsky JA
    J Immunol; 1995 Mar; 154(6):2733-42. PubMed ID: 7533182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus mutation affects proteasomal epitope processing.
    Seifert U; Liermann H; Racanelli V; Halenius A; Wiese M; Wedemeyer H; Ruppert T; Rispeter K; Henklein P; Sijts A; Hengel H; Kloetzel PM; Rehermann B
    J Clin Invest; 2004 Jul; 114(2):250-9. PubMed ID: 15254592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes.
    Harcourt GC; Lucas M; Sheridan I; Barnes E; Phillips R; Klenerman P
    J Viral Hepat; 2004 Jul; 11(4):324-31. PubMed ID: 15230855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.
    Urbani S; Uggeri J; Matsuura Y; Miyamura T; Penna A; Boni C; Ferrari C
    Hepatology; 2001 Jun; 33(6):1533-43. PubMed ID: 11391544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different hepatitis C virus nonstructural protein 3 (Ns3)-DNA-expressing vaccines induce in HLA-A2.1 transgenic mice stable cytotoxic T lymphocytes that target one major epitope.
    Brinster C; Muguet S; Lone YC; Boucreux D; Renard N; Fournillier A; Lemonnier F; Inchauspé G
    Hepatology; 2001 Dec; 34(6):1206-17. PubMed ID: 11732011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition.
    Wang H; Eckels DD
    J Immunol; 1999 Apr; 162(7):4177-83. PubMed ID: 10201944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection.
    Hiroishi K; Kita H; Kojima M; Okamoto H; Moriyama T; Kaneko T; Ishikawa T; Ohnishi S; Aikawa T; Tanaka N; Yazaki Y; Mitamura K; Imawari M
    Hepatology; 1997 Mar; 25(3):705-12. PubMed ID: 9049223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
    J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inefficient recognition of autologous viral sequences by intrahepatic hepatitis C virus-specific cytotoxic T lymphocytes in chronically infected subjects.
    Giuggio VM; Bonkovsky HL; Smith J; Rothman AL
    Virology; 1998 Nov; 251(1):132-40. PubMed ID: 9813209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8(+) T cells in patients with chronic infection.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; Wright TL; Greenberg HB
    J Immunol Methods; 2004 Apr; 287(1-2):91-9. PubMed ID: 15099758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection.
    Gaudieri S; Rauch A; Park LP; Freitas E; Herrmann S; Jeffrey G; Cheng W; Pfafferott K; Naidoo K; Chapman R; Battegay M; Weber R; Telenti A; Furrer H; James I; Lucas M; Mallal SA
    J Virol; 2006 Nov; 80(22):11094-104. PubMed ID: 17071929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T lymphocyte responses in hepatitis C virus infection.
    Imawari M; Kita H; Moriyama T; Kaneko T; Hiroishi K
    Princess Takamatsu Symp; 1995; 25():221-5. PubMed ID: 8875627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.